Europe: Publication of the regulation on monacolins from red yeast rice

This article is extracted from our regulatory and scientific database NOL Data Solution. More than 3,000 ingredients with their regulatory status for Europe, US and Asia at your fingertips to create compliant products.

Regulation (EU) 2022/860 of 1 June 2022 amending Annex III to Regulation (EC) 1925/2006 as regards monacolins from red yeast rice has been published on the Official Journal of the European Union on 2 June 2022 and will apply from 22 June 2022 (with no transition period).

This regulation adds monacolins from red yeast rice:

  • in Part B of Annex III to Regulation (EC) 1925/2006 (under restrictions):

Dose of monacolins < 3 mg / day (to be indicated on the label: content of monacolins per portion of the product and number of individual portions of the product for maximum daily consumption). 

Mandatory warnings: Warning not to consume a daily amount of 3 mg of monacolins from yeast rice or more. “Should not be consumed by pregnant or lactating women, children below 18 years old and adults above 70 years old”. “Seek advice from a doctor on consumption of this product if you experience any health problems”; “Should not be consumed if you are taking cholesterol-lowering medication”; “Should not be consumed if you are already consuming other products containing red yeast rice”.

  • and in Part C of Annex III to Regulation (EC) 1925/2006, i.e. under Union scrutiny (under scrutiny because of scientific uncertainty: the industry will have 18 months to submit additional scientific data demonstrating the safety of the substances for a possible new assessment by EFSA; and the Commission should take a decision within four years).

Recital 6 of this regulation reminds that the use of red yeast rice preparations in food categories other than food supplements is is not authorized (subject to an authorisation under Regulation (EU) 2015/2283 on novel foods).

In conclusion, from 22 June 2022, all food supplements with a daily dose of monacolins from red yeast rice greater than or equal to 3 mg/day will be banned at European level, and the mandatory mentions and warnings must be present on the labelling of food supplements with a daily dose of monacolins from red yeast rice lower than 3 mg/day.

NOL Data Solution
NOL Compliance